<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000367462"><TermName>satraplatin</TermName><TermPronunciation>(SA-truh-PLA-tin)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of prostate and other types of cancer. It contains the metal platinum and may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called BMS-182751 and JM 216.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711595" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;satraplatin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711594" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;satraplatino&quot;" language="es" id="_4"/><SpanishTermName>satraplatino</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del cáncer de próstata y otros tipos de cáncer. Contiene el metal platino y podría destruir las células cancerosas al dañar su ADN e impedir su multiplicación. Es un tipo de alquilante. También se llama BMS-182751 y JM 216.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-04-23</DateFirstPublished><DateLastModified>2008-11-14</DateLastModified></GlossaryTerm>
